Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private

BSE326.202.9 (+0.9 %)

PREV CLOSE ( ) 323.30

OPEN PRICE ( ) 321.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15722

TODAY'S LOW / HIGH ( )315.60 335.55

52 WK LOW / HIGH ( )260 501.6

NSE326.803.65 (+1.13 %)

PREV CLOSE( ) 323.15

OPEN PRICE ( ) 320.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 463824

TODAY'S LOW / HIGH( ) 316.00 336.25

52 WK LOW / HIGH ( )259.5 500

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1987

Management Info

Omprakash Inani - Chairman Vishnukant Bhutada - Managing Director

Registered Office

Address Shilpa House,#12-6-214/ A1,Hyderabad Road,
Raichur,
Karnataka-584135

Phone 08532-238704

Email info@vbshilpa.com

Website www.vbshilpa.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

13Feb Shilpa Medicare enters into strategic
Shilpa Medicare has entered into strategic partnership for a long-term d..

13Feb Shilpa Medicare gains on entering into
Shilpa Medicare is currently trading at Rs. 329.00, up by 5.70 points or..

13Feb Shilpa Medicare informs about updates
Shilpa Medicare has informed that it has entered into a binding agreemen..

28Jan Shilpa Medicare’s arm gets Orphan Drug
Shilpa Medicare’s wholly owned subsidiary -- Shilpa Biologicals together..

15Jan Shilpa Medicare informs about disclos
In terms of Regulation 30 read with Schedule III and other applicable pr..

Financials

Rs. in Millions

	QTR Dec 25	ANNUAL 25
Net Profit	159.34	698.02
Gross Profit	237.85	1072.37
Operating Profit	422.95	2084.35
Net Sales	1657.05	4773.42

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 13043.80 (0.65%)	M.Cap ( in Cr)16735.05
Kwality Pharma (BSE) 1431.20 (5.08%)	M.Cap ( in Cr)1485.04
Sanofi Cons. Health (BSE) 4299.65 (1.54%)	M.Cap ( in Cr)9902.36
Astrazeneca Pharma I (BSE) 8878.75 (0.59%)	M.Cap ( in Cr)22196.88
NGL Fine-Chem (BSE) 2291.65 (2.29%)	M.Cap ( in Cr)1415.79

Shareholding Pattern

	NON-INSTITUTION	40.56%
	PROMOTERS	40.13%
	MUTUAL FUNDS/UTI	5.2%
	FI/BANKS/INSURANCE	1.79%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru Pharma He...	1.50
ITI Pharma & Health...	1.16
Bandhan Innovation ...	1.15
WOC Special Opp Fun...	0.88
Bandhan Small Cap F...	0.75
ICICI Pru ELSS Tax ...	0.63
Motilal Oswal Nifty...	0.62

Risk Disclosures on Derivatives

Smart Quotes

SHILPA MEDICARE LTD.